Eric Wachter - CTO at Provectus Biopharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Cto
Stock Symbol
PVCT on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Eric Wachter since 10/18/2023

Holdings reported by Eric Wachter for Provectus Biopharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Series D-1 Convertible Preferred Stock 1.39M Jun 20, 2021 Direct Common Stock
8% Secured Convertible Promissory Notes due 2021 0 Jun 20, 2021 Direct Series D-1 Convertible Preferred Stock

Transactions reported by Eric Wachter for Provectus Biopharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.